Objectives: Although the most accepted mechanisms of action of amphotericin B and azoles are related to ergosterol, it is possible that these drugs have other effects on the fungal cell. In the present study, the role of endogenous reactive oxygen species (ROS) and peroxynitrite produced by azoles and amphotericin B in the fungus Cryptococcus gattii were examined.
Introduction
Cryptococcus gattii and Cryptococcus neoformans are the main aetiological agents of the human and animal fungal disease cryptococcosis. 1 The infection is usually acquired by inhalation of environmental basidiospores or desiccated yeasts. 2 Cryptococcal disease in humans involves pulmonary and cutaneous sites, but the most severe manifestation is the CNS involvement with meningoencephalitis. 1 Despite the similarities of the clinical syndromes in cryptococcosis, immunocompromised patients are more frequently infected by C. neoformans, while C. gattii has emerged as an important cause of infection in immunocompetent individuals. 3, 4 It is well established that the infection caused by C. gattii has a less favourable response to antifungal therapy and a relatively worse prognosis compared with the infection caused by C. neoformans. 5, 6 Usually, clinical manifestations of the C. gattii infection include severe or prolonged cough, pneumonia, shortness of breath, sputum production, sinusitis, muscle soreness, blurred or double vision, seizures, headache, sharp chest pain, fever, weight loss, skin lesions, change in mental status and a general feeling of discomfort. 7, 8 A small number of antimycotic drugs with different modes of action and target spectra are available to treat these diseases, with polyenes and azoles being the most used against cryptococcosis. 1 The polyenes, represented by amphotericin B, bind to ergosterol, the major sterol in the fungal cell membrane, and form pores, thereby causing membrane damage. The azoles (e.g. fluconazole and itraconazole) affect sterol biosynthesis by inhibiting sterol 14-a-demethylase, which results in ergosterol depletion and accumulation of toxic methylated sterols. 9 Interestingly, resistance to antifungal drugs has been demonstrated among clinical strains of Cryptococcus spp. 10 and the investigation of this phenomenon considering the drugs amphotericin B and azoles against C. gattii is very important. Although the above-mentioned mechanisms of action are the most accepted for amphotericin B and azoles, several reports suggested that these antifungals have other effects on the fungal cell. In particular, it has been suggested that amphotericin B can be auto-oxidized with the subsequent production of oxygen free radicals. 11 Other researchers suggested that amphotericin B rapidly induces a strong oxidative burst in C. neoformans. 12 On the other hand, the importance of the enhanced production of reactive oxygen species (ROS) and reactive nitrogen species (RNS) on the antifungal activity and its influence on the pathogen's antioxidant defence system remains unclear. Regarding the azoles, some studies described that the activity of miconazole against Candida albicans may be related to ROS production. 13, 14 However, these researchers did not focus on the role of ROS production in the antifungal effect of fluconazole and itraconazole (the main azoles used in cryptococcosis treatment). Furthermore, recent studies demonstrated that C. gattii possesses an arsenal of ROS scavengers, 15 suggesting a cytoprotective mechanism against endogenous and exogenous ROS.
Indeed, there is no study focused on the importance of RNS in the microbial susceptibility to the antifungals. Therefore, we evaluated distinct parameters involved in the oxidative and nitrosative bursts generated by fluconazole, itraconazole and amphotericin B against C. gattii.
Materials and methods

C. gattii strains and study design
We tested three clinical strains of C. gattii (L135/03, L27/01 and 23/10993), all from the culture collection of the Laborató rio de Micologia of Universidade Federal de Minas Gerais, Brazil, and one reference strain (ATCC 32068) from the culture collection of the University of Georgia, Atlanta, GA, USA. The isolates were maintained on slants of Sabouraud dextrose agar (SDA; Difco Laboratories, Detroit, MI, USA) at 48C. Prior to each test, the strains were subcultured on SDA for 48 h at 358C. The following assays were performed with all the strains: antifungal drug susceptibility testing, time-kill curves and in vitro interaction of fluconazole, itraconazole, amphotericin B and hydrogen peroxide with 3-amino-1,2,4-triazole (3-AT), diethyldithiocarbamate (DETC) and 5,10,15,20-tetrakis (4 ′ -sulfphonatophenyl) porphyrinato iron III (FETPPS). The reference strain ATCC 32068 was chosen for determination of the ergosterol content, lipid peroxidation, enzyme activities and the amount or ROS and RNS.
Antifungal drug susceptibility testing
The MICs of fluconazole (Sigma-Aldrich, St Louis, MO, USA), itraconazole (Sigma-Aldrich), amphotericin B (Sigma-Aldrich) and hydrogen peroxide (Sigma-Aldrich) were determined by the antifungal microdilution susceptibility standard test proposed in the CLSI M27-A3 method. 16 The inoculum was prepared in sterile saline and the transmittance of the suspensions was adjusted to 75%-77% (530 nm), followed by further dilution in RPMI-1640 buffered with MOPS (Sigma-Aldrich) medium to achieve 1.0×10 3 -5.0×10 3 cfu/mL. Fluconazole was dissolved in sterile distilled water, while itraconazole and amphotericin B were dissolved in 100% DMSO at 1000 mg/mL. These stock solutions and hydrogen peroxide were further diluted in RPMI-1640 (Sigma-Aldrich) to yield twice the final strength required for the test. The final concentrations ranged from 0.125 to 64 mg/L for fluconazole, 0.03 to 16 mg/L for itraconazole and amphotericin B, and 53.1×10 2 to 27.2×10 4 mg/L for hydrogen peroxide. 16 A 100 mL volume of the inoculum suspension was transferred to sterile flat-bottomed 96-well plates containing 100 mL of each of the antifungals or RPMI-1640 (growth control). The plates were incubated at 358C for 72 h. The MICs of fluconazole and itraconazole were determined visually as 80% growth inhibition, while for amphotericin B and hydrogen peroxide, the reading was performed as 100% growth inhibition when compared with the control. The results were confirmed by adding the salt MTT (Sigma-Aldrich) (5.0 mg/mL) to determine the reduction in the metabolic cell activity. Briefly, the plates were incubated at 358C for 3 h and DMSO was added before spectrophotometric reading at 490 nm. The MIC endpoint for interpreting the results was 80% of reduction in metabolic activity for azoles and 100% of reduction in metabolic activity for amphotericin B and hydrogen peroxide compared with the control (no drug). The isolate Candida parapsilosis ATCC 22019 was used as a quality control. 16 All the tests were performed in duplicate for each strain.
Time -kill curves
An assay was performed to evaluate the time-kill kinetics of the drugs against C. gattii strains. For fluconazole, itraconazole, amphotericin B and hydrogen peroxide, the concentration tested was equivalent to the MIC or 2× MIC for each strain, as described previously. 17 The inoculum was prepared in sterile saline and the transmittance of the suspensions was adjusted to 75% (530 nm), followed by further dilution in RPMI-1640 medium to achieve 1.0×10 3 -5.0×10 3 cfu/mL. A 100 mL aliquot of C. gattii inoculum was taken from the microtitre plates containing the MIC and 2× MIC of each antifungal agent at different intervals until 72 h and plated on SDA. The plates were incubated at 358C for 72 h prior to colony counting. The results were expressed as the percentage of growth compared with that of the growth control for each time analysed. The data represent the means of three independent experiments in duplicate assays.
Lipid peroxidation assay
The strain C. gattii ATCC 32068 was cultured (358C for 72 h) on SDA and 20.0 mg of the fungal cell mass was transferred to polypropylene tubes, followed by treatment with 8× MIC of the test drugs for 1 or 24 h at 358C. A growth control was also performed. After the incubation, the tubes were centrifuged (Jouan, model BR4i) at 1643 g for 5 min at 48C and the supernatant was removed. The cells were washed with sterile distilled water and the net wet weight pellet was determined.
The products of lipid peroxidation were measured as thiobarbituric acid-reactive substances (TBARSs). 18 The pellet was frozen and homogenized in 1000 mL ice-cold 1.1% phosphoric acid. The homogenate (400 mL) was mixed with 400 mL of 1% thiobarbituric acid (SigmaAldrich) prepared in 50 mM NaOH containing 0.1 mM butylated hydroxytoluene and 200 mL of 7% phosphoric acid (all the solutions were kept on ice during manipulation). Subsequently, samples (pH 1.5) were heated for 60 min at 988C and 1500 mL of butanol was added. The mixture was mixed vigorously using a vortex and centrifuged for 5 min at 2000 g. The organic layer was transferred and the absorbance at 532 nm was measured (Thermo Scientific Multiskan Spectrum, Thermo Fisher Scientific). The thiobarbituric acid solution was replaced with 3 mM HCl in the blank controls. The TBARS values were expressed using the extinction coefficient of 156 mM 21 cm 21 . The results represent the means of three independent experiments. Ferreira et al.
Ergosterol quantification
The cells were treated as outlined in the preceding Lipid peroxidation assay section. The ergosterol quantification in the fungal cell membrane was performed as described previously. 17 For the extraction of lipids, 3000 mL of an ethanolic solution of 25% potassium hydroxide was added to each cell mass and agitated for 1 min. The tubes were incubated in a water bath at 858C for 1 h and further cooled at room temperature. A mixture of 1 mL of sterile water and 3000 mL of n-heptane (Sigma-Aldrich) was added, followed by agitation in a vortex for 3 min. The supernatant was removed and the reading was performed using a spectrophotometer at 282 and 230 nm. A calibration curve with standard ergosterol (Sigma-Aldrich) was constructed and used to calculate the amount of ergosterol. The results were expressed as the percentage of ergosterol in comparison with the growth control and represent the means of three independent experiments.
Measurement of ROS and peroxynitrite production
Endogenous amounts of ROS and peroxynitrite were measured by fluorometric assay with specific probes.
13,19 1.0×10 5 cells/mL of C. gattii ATCC 32068 were treated with the MIC of fluconazole, itraconazole, amphotericin B or hydrogen peroxide in RPMI-1640 without phenol red (Sigma-Aldrich) (data not shown) and incubated with 10 mM 2 ′ ,7 ′ -dichlorofluorescein diacetate (Invitrogen, Life Technologies, Carlsbad, CA, USA) for ROS quantification or 20 mM dihydrorhodamine 123 (Invitrogen) for peroxynitrite quantification. The fluorescence was measured with a fluorometer (Synergy 2 SL Luminescence Microplate Reader; Biotek) using excitation and emission wavelengths of 500 nm. The kinetics of ROS and peroxynitrite production were performed at 0, 0.5, 1 and 24 h. The data are expressed as arbitrary units of fluorescence+SEM. These tests were performed in triplicate.
Enzymatic activity of the antioxidant system
Prior to the tests, a cell-free extract from C. gattii ATCC 32068 treated with the antifungals was prepared according to the method described by Khan et al., 20 with minor modifications. Untreated cells were used as control. Cells (20.0 mg wet weight) were treated with 8× MIC of the drugs. Aiming the evaluation of the oxidative burst on the action of the antifungals, these drugs were combined with the catalase-specific inhibitor 3-AT (Merck, Rahway, NJ, USA) at 10 mM, 21 the superoxide dismutase (SOD) 1 inhibitor DETC (Merck) at 1 mM 22 and the peroxynitrite scavenger FETPPS (Merck) at 12.5 mM 23 for 24 h at 358C. A growth control was also performed. These cells were centrifuged and suspended in 2 mL of grinding medium (250 mM sucrose/10 mM Tris-HCl, pH 7.5/1 mM PMSF) and 100 mg of glass beads (0.45 mm). The suspension was disrupted mechanically in a vortex mixer for five cycles of 270 s each of 10000 vibrations/min. The homogenate was collected and centrifuged at 1000 g for 5 min at 48C to remove unbroken cells and glass beads and further centrifuged at 15000 g for 40 min at 48C. The supernatant was used as a cell-free extract. Soluble protein was determined using the biuret test using a standard curve of BSA. 24 
SOD activity
The SOD activity was measured by the inhibition of pyrogallol autoxidation as described previously, 20, 25 with modifications. The control was performed as 100 mL of grinding medium plus 100 mL pyrogallol (20 mM; Sigma-Aldrich) diluted in PBS (pH 8.5). Both solutions were freshly prepared at the time of the assay. In the test samples, 100 mL of cell-free extract was added to pyrogallol and the inhibition of autoxidation was monitored every 30 s for 3 min at a wavelength of 420 nm. The units of SOD were considered as pyrogallol autoxidation per 200 mL, calculated 
Peroxidase (PER) activity
The PER activity was determined according to the methodology proposed previously 19 and measured in a system containing hydrogen peroxide and guaiacol as substrate. The absorbance changes at l¼470 nm were monitored using a molar extinction coefficient value of 26.61 M 21 cm 21 for the product tetraguaiacol formed by the enzymatic reaction. Briefly, 100 mL of the cell-free extract was incubated for 13 min in HEPES solution (25 mM, pH 6.8) containing 10 mM hydrogen peroxide and 4 mM guaiacol (Sigma-Aldrich). The change in absorbance caused by the formation of tetraguaiacol at 470 nm was monitored every 30 s for 3 min of reaction. The least count of the absorbance measurement was 0.001 and one enzyme unit is the amount of enzyme that produces 1 nmol/min of product. The results are expressed in nmol/min/mg of protein and represent the means of three independent experiments.
In vitro interaction of fluconazole, itraconazole, amphotericin B and hydrogen peroxide with 3-AT, DETC and FETPPS Fluconazole, itraconazole, amphotericin B and hydrogen peroxide were also tested in combination with the catalase-specific inhibitor 3-AT, the SOD1 inhibitor DETC and the peroxynitrite scavenger FETPPS. A chequerboard microdilution method, 26 which provides a matrix of all possible drug combinations in the required concentration range, was used to test the susceptibility of the four C. gattii strains to the drugs. The concentrations ranged from 0.25 to 64 mg/L for fluconazole, 0.03 to 0.5 mg/L for itraconazole, 0.06 to 1 mg/L for amphotericin B and 2.1×10 3 to 34×10 3 mg/L for hydrogen peroxide. Furthermore, the concentrations ranged from 5 to 40 mM for 3-AT, 0.5 to 4 mM for DETC and 6.25 to 50 mM for FETPPS. These ranges were used based on the MIC found in the antifungal drug susceptibility testing. The inoculum was prepared as described in the Antifungal drug susceptibility testing section. A volume of 100 mL of the inoculum suspension was transferred to sterile flat-bottomed 96-well plates containing 50 mL of each of the antifungal drugs and 50 mL of each inhibitor/scavenger or RPMI-1640 (growth control). The plates were incubated at 358C for 72 h. The cellular metabolic activity was determined using the MTT salt.
Interaction between the drugs was quantitatively evaluated by determining the fractional inhibitory concentration index (FICI) 27 and also by the construction of interaction curves. The formula for calculating the 
Statistical analysis
All statistical analyses were performed using GraphPad Prism version 5.00 for Windows (GraphPad Software, San Diego, CA, USA). A one-way ANOVA using a Kruskal-Wallis non-parametric test was used to statistically compare the differences among groups. Individual comparison between groups was done using the Bonferroni post test. A 95% CI was considered in all experiments.
Results
Antifungal drug susceptibility testing and time -kill curves
In the antifungal susceptibility testing, the MIC range values for fluconazole and itraconazole were 4.0-32.0 and 0.125-0.5 mg/L, respectively. For amphotericin B and hydrogen peroxide, the MIC range values were 0.12 -0.25 mg/L and 8.5×10
3 mg/L, respectively (Table 1) . To evaluate the kinetics of the action of the antifungal agents tested, the time -kill curve assay was performed. Fluconazole and itraconazole provided fungistatic curves, with reduction of 80% of growth after 36 and 12 h of incubation at the MIC and 2× MIC, respectively. On the other hand, amphotericin B and hydrogen peroxide at the MIC and 2× MIC provided similar curves, with complete reduction of growth after 24 h (Figure 1 ).
Lipid peroxidation is important for the effect of the antifungal agents
Our results showed high levels (P,0.05) of TBARSs after 1 h of treatment with itraconazole, amphotericin B and hydrogen peroxide, indicating damage of the lipids compared with the growth control (Figure 2a) . It should be noted that lipid peroxidation only remained higher after 24 h when amphotericin B and hydrogen peroxide were tested (P,0.05) (Figure 2a) . Fluconazole did not influence the levels of TBARSs. Interestingly, the ergosterol levels were reduced for all drugs tested after 1 h of treatment (P,0.05) in comparison with the growth control. After 24 h, these levels remained lower (P,0.05) for fluconazole and itraconazole ( Figure 2b ). It is well established that lipid peroxidation is mediated by free radicals. Thus, it was hypothesized that this effect may be related to ROS or RNS.
Antifungal drugs lead to ROS and peroxynitrite production in C. gattii
Since the treatment of C. gattii cells with itraconazole and amphotericin B enhanced the levels of TBARSs (Figure 2) , it was hypothesized that ROS/peroxynitrite may be important to the effect of the antifungals. Itraconazole resulted in increasing ROS levels compared with the growth control at the beginning of the treatment (P,0.05) (Figure 3a) . Treatment with amphotericin B resulted in a significantly enhanced production of ROS throughout the protocol (P,0.05) (Figure 3a ). There was a tendency to increase the peroxynitrite levels by the cells treated with amphotericin B at times 0 and 0.5 h (P ¼0.07) (Figure 3b ). Hydrogen peroxide induced the production of high levels of ROS and peroxynitrite at all times tested (P,0.05). Itraconazole and amphotericin B induced the production of free radicals, which probably are responsible for the lipid peroxidation observed (Figure 3c) . Furthermore, the ability of C. gattii to adapt to these higher levels of ROS and RNS through increasing PER and SOD activities was verified.
Antifungal drugs increased the activities of the antioxidant enzymes PER and SOD
To determine whether treatment with fluconazole, itraconazole, amphotericin B and hydrogen peroxide influences the antioxidant enzymes, the activities of SOD and PER were assessed. The results showed that SOD activity was higher (P,0.05) in cells exposed to itraconazole and hydrogen peroxide compared with the growth control ( Figure 4a ) and PER activity was higher (P,0.05) in cells exposed to itraconazole, amphotericin B and hydrogen peroxide (Figure 4b ). To further explore the relationship between antioxidant enzymes and the stress response mediated by the antifungals, SOD activity in the presence of the catalase inhibitor 3-AT and PER activity in the presence of the Cu,Zn-isoenzyme-SOD1 inhibitor DETC (Figure 4a-c) were measured. The PER activity was significantly diminished (P,0.05) when fungal cells were treated with itraconazole, amphotericin B and hydrogen peroxide in the presence of DETC (Figure 4b ), but the PER inhibition did not alter the SOD activity (Figure 4a) . These results suggest a functional role of SOD and a possible connection between these enzymes in regulating responses to these drugs.
The SOD and PER activities were also analysed in the presence of FETPPS, a scavenger of peroxynitrite (Figure 4) . It was noted that the activity of PER was reduced in the presence of FETPPS when the yeast cells were treated with itraconazole, amphotericin B and hydrogen peroxide (Figure 4b) . FETPPS led to a 
Inhibition of PER, SOD and peroxynitrite alters the activities of antifungal drugs
To determine the influence of the antioxidant enzymes and peroxynitrite/ROS production on the C. gattii tolerance of the antifungal drugs, we tested 3-AT, DETC and FETPPS in combination with azoles, amphotericin B and hydrogen peroxide. A synergistic effect of 3-AT with itraconazole (FICI ¼0.5), amphotericin B (FICI¼ 0.5) and hydrogen peroxide (FICI ¼ 0.5) was observed ( Figure 5a and Table 1 ). A synergist effect of DETC with amphotericin B (FICI ¼0.5) and hydrogen peroxide (FICI¼ 0.5) was also noted (Figure 5b and Table 1 ).
An antagonistic effect was observed in the interaction between amphotericin B plus hydrogen peroxide (FICI¼ 4.5) and amphotericin B plus FETPPS (FICI¼ 5) (Figure 5c and Table 1 ). It is important to note that the curves of the combination between FETPPS and amphotericin B or hydrogen peroxide (Figure 5c ) presented the same profile, which is characteristic of an antagonistic interaction.
A schematic association of all the data obtained from the experiments involving the oxidative and nitrosative bursts in the mechanism of action of azoles and amphotericin B is proposed in Figure 6 .
Discussion
The C. gattii immunoproteome project identified a great part of the antioxidant defence system of this yeast. 28 However, little is known about the activity of antioxidant enzymes in C. gattii in the presence of antifungal compounds and its susceptibility to oxidative and nitrosative challenges. In this study, we have provided evidence that itraconazole and amphotericin B induce the production of free radicals in C. gattii cells. Also, the role of ROS and RNS during the action of the antifungals is proposed.
Itraconazole, an orally active broad-spectrum triazole antimycotic, has anti-Cryptococcus activity in vitro and in animal models of cryptococcal meningitis. 29 High levels of TBARSs were observed after 1 h of C. gattii treatment with itraconazole, but not with fluconazole. The assays showed that high lipid peroxidation occurred together with a reduction of the ergosterol content after 1 h of treatment with itraconazole. The data indicated that these two events occur simultaneously. Therefore, we decided to measure peroxynitrite and ROS produced by C. gattii cells after treatment with itraconazole. The results show that itraconazole resulted in an increase in the intracellular amount of ROS. Based on these data, it was hypothesized that this drug does not have a unique target in the cell: itraconazole also induces the production of ROS, leading to lipid peroxidation, which corresponds to the oxidative degradation of lipids, in which a free radical chain 'steals' electrons from the lipids (mainly polyunsaturated fatty acids) in cell membranes, resulting in cell damage. This phenomenon would happen in a dynamic way together with inhibiting sterol 14a-demethylase, 9 explaining the fact that the MIC for itraconazole is always lower than for fluconazole for almost all yeasts. 30, 31 In addition, fluconazole was not able to induce ROS, RNS and lipid peroxidation.
We observed no significant lipid peroxidation after 24 h of treatment with itraconazole; on the other hand, it was possible to note an increase in PER and SOD activities at this time. Synergism between itraconazole and 3-AT, a catalase inhibitor, was also verified. These results suggest that oxidative stress in C. gattii exposed to itraconazole occurs more significantly at the beginning of the treatment and contributes to the antifungal effect. It is probable that the cells which survive to the ROS have increased antioxidant activity. This hypothesis helps to explain the fact that itraconazole is a fungistatic drug. 32 Amphotericin B is an antifungal agent that presents potent activity against the majority of fungi, including yeast and moulds. 33 It is an oxidizing molecule, which may be related to the oxidative burst. 11 In our experiments, amphotericin B and hydrogen peroxide provided similar time -kill curves, damage to lipids and interaction with 3-AT, DETC and FETPPS: TBARS levels were increased after 1 and 24 h of treatment with these two drugs. Therefore, we also decided to measure peroxynitrite and ROS produced by C. gattii cells after treatment with amphotericin B. The results showed that amphotericin B induced high levels of ROS and peroxynitrite immediately after contact with this drug and the oxidative burst continued to be enhanced after 24 h.
Our data reinforce that amphotericin B, like itraconazole, has multiple effects on the cell, as suggested previously. 12, 34 We suggest that amphotericin B has two fungicidal mechanisms: oxidative and nitrosative bursts plus increased cellular permeability. In addition, C. gattii enhanced the activity of its antioxidant system in response to the oxidative and nitrosative bursts. 35, 36 The assays demonstrated increased PER activity after 24 h of treatment with amphotericin B, besides synergism between amphotericin B and 3-AT and between amphotericin B and DETC. However, this activation of the antioxidant system may not be sufficient to neutralize all the ROS and RNS, which does not allow an efficient cellular adaptation to this stress ( Figure 6 ). It also explains the lower resistance rate to amphotericin B described among clinical strains of C. gattii when compared with azoles. 10 Peroxynitrite is a short-lived species that is a potent inducer of cell death. 37 Although peroxynitrite is not a free radical by chemical nature (as it has no unpaired electron), it is a powerful oxidant exhibiting a wide array of tissue-damaging effects, including lipid peroxidation, inactivation of enzymes and other effects in the cell. 38 The present study demonstrated that the Oxidative and nitrosative bursts caused by antifungals in C. gattii 9 of 11 addition of FETPPS, a scavenger of peroxynitrite, diminished SOD activity after all treatments tested (included growth control). In this context, it was previously shown that nitric oxide efficiently competes with SOD for superoxide. 39 Overall, peroxynitrite was constantly removed from system by FETPPS, probably shifting the equilibrium to the formation of this species by the reaction between nitric oxide and superoxide. 37 Moreover, the activity of PER was also reduced when FETPPS was added to the cells treated with itraconazole and amphotericin B. These results may be explained by the reduction of its substrate (hydrogen peroxide), which may be caused by the reduced activity of SOD.
Finally, our data showed an interesting role of oxidative and nitrosative bursts caused by azoles and amphotericin B against the fungal pathogen C. gattii. We believe that these findings are important to a better understanding of the mechanism of action of these drugs and the emergence of resistant strains.
